What’s new

• Shree Ganesh Bio-Tech sold 86.48 lakh shares (3.39% stake) in Suncare Traders between April 1 and June 22, 2026.
• Holding fell from 5.28% to 1.89%, crossing below the 5% substantial acquisition threshold.
• The exit comes just months after acquiring the stake, signaling a swift reversal of strategic interest.

Why it matters

For a ₹11 crore nano-cap already suffering a 46.7% revenue decline and a 556.2% PAT plunge, rapid shareholder churn undermines liquidity and confidence. The drop below 5% removes future disclosure obligations, making any further sales invisible to the market.

What we’re watching

• Whether any new substantial shareholder emerges to stabilize ownership.
• Impact on stock liquidity and price discovery for the thinly traded counter.
• Any regulatory scrutiny given the speed of entry and exit.

The full read

Shree Ganesh Bio-Tech (India) Limited sold 86.48 lakh shares of Suncare Traders Ltd between April 1 and June 22, 2026, cutting its stake from 5.28% to 1.89%. The open-market transactions removed 3.39% of the company's equity. The exit is a quick reversal—the entity had built that stake only months earlier. For a nano-cap worth ₹11 crore, such churn is material. The drop below 5% means no more disclosure requirements for Shree Ganesh, making further moves invisible. With Suncare's revenue down 46.7% and PAT down 556% in trailing data, the departure erodes investor confidence.

Primary source: BSE · NSE